ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53

Acute myeloid leukaemia is a complex, highly aggressive hematopoietic disorder. Currently, in spite of great advances in radiotherapy and chemotherapy, the prognosis for AML patients with initial treatment failure is still poor. Therefore, the need for novel and efficient therapies to improve AML tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lanlan, Feng, Yubin, Hu, Shuang, Du, Yan, Xu, Xiaoling, Zhang, Meiju, Peng, Xiaoqing, Chen, Feihu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178252/
https://www.ncbi.nlm.nih.gov/pubmed/33960640
http://dx.doi.org/10.1111/jcmm.16539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178252/
https://www.ncbi.nlm.nih.gov/pubmed/33960640
http://dx.doi.org/10.1111/jcmm.16539

Ejemplares similares